ArticleJCO precision oncology2019

Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience.

Brandon L Swed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.